{"id":"topical-corticosteroids","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Systemic absorption (with prolonged use on large areas)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These agents penetrate the skin and bind intracellular glucocorticoid receptors, leading to suppression of pro-inflammatory cytokine production, reduced immune cell infiltration, and decreased vasodilation. This results in reduced erythema, pruritus, and other inflammatory manifestations of dermatological conditions. Potency varies by formulation and molecular structure.","oneSentence":"Topical corticosteroids suppress local immune and inflammatory responses by binding to glucocorticoid receptors in skin cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:17.883Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory skin conditions including eczema, psoriasis, and dermatitis"},{"name":"Pruritus and other allergic skin reactions"},{"name":"Lichen planus and other inflammatory dermatoses"}]},"trialDetails":[{"nctId":"NCT07496060","phase":"PHASE4","title":"Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-08-10","conditions":"Anterior Chamber Granulomatous Uveitis","enrollment":66},{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT07168148","phase":"PHASE2","title":"Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2025-11-10","conditions":"Nasal Obstruction, Chronic Rhinitis","enrollment":3},{"nctId":"NCT06311682","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis","status":"RECRUITING","sponsor":"LEO Pharma","startDate":"2024-06-10","conditions":"Atopic Dermatitis","enrollment":195},{"nctId":"NCT05401201","phase":"NA","title":"Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koite Health Oy","startDate":"2023-02-24","conditions":"Oral Lichen Planus, Dental Plaque, Oral Bacterial Infection","enrollment":60},{"nctId":"NCT05492578","phase":"PHASE2, PHASE3","title":"Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials","status":"ENROLLING_BY_INVITATION","sponsor":"Sanofi","startDate":"2022-08-22","conditions":"Dermatitis Atopic","enrollment":1663},{"nctId":"NCT07234838","phase":"","title":"Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)","status":"RECRUITING","sponsor":"Jonathan Krygier","startDate":"2026-02-01","conditions":"Psoriasis, Condyloma Acuminata, Biotherapies","enrollment":600},{"nctId":"NCT07453238","phase":"PHASE4","title":"Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata","status":"NOT_YET_RECRUITING","sponsor":"Hayat Abad Medical Complex, Peshawar","startDate":"2026-04-01","conditions":"Alopecia Areata","enrollment":60},{"nctId":"NCT07336368","phase":"PHASE3","title":"Topical Cryotherapy and Keloid/Hypertrophic Scars","status":"RECRUITING","sponsor":"Sonal Choudhary","startDate":"2026-03","conditions":"Keloid Scars, Hypertrophic Scars","enrollment":30},{"nctId":"NCT06981767","phase":"PHASE2","title":"Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-18","conditions":"Oral Lichen Planus","enrollment":42},{"nctId":"NCT06701331","phase":"PHASE3","title":"Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2024-12-22","conditions":"Atopic Dermatitis","enrollment":99},{"nctId":"NCT05953090","phase":"NA","title":"VALOR: Vaginal Atrophy & Long-term Observation of Recovery","status":"RECRUITING","sponsor":"Stratpharma AG","startDate":"2023-10-30","conditions":"Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause","enrollment":2000},{"nctId":"NCT05626478","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2023-06-01","conditions":"Corneal Edema, Corneal Defect, Anterior Chamber Inflammation","enrollment":50},{"nctId":"NCT05436535","phase":"PHASE4","title":"Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-11-21","conditions":"Atopic Dermatitis","enrollment":433},{"nctId":"NCT06241118","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-02-29","conditions":"Dermatitis Atopic","enrollment":390},{"nctId":"NCT07405489","phase":"","title":"Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH","status":"COMPLETED","sponsor":"Benha University","startDate":"2021-01-01","conditions":"VKH Syndrome","enrollment":30},{"nctId":"NCT07401992","phase":"PHASE4","title":"Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2026-01-15","conditions":"Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2","enrollment":62},{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT02360202","phase":"PHASE4","title":"Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-02-17","conditions":"Bullous Pemphigoid","enrollment":30},{"nctId":"NCT06871904","phase":"PHASE1, PHASE2","title":"Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2025-04-07","conditions":"Oral Submucous Fibrosis","enrollment":45},{"nctId":"NCT06865170","phase":"PHASE4","title":"Pain Perception During Intra-Articular Knee Joint Injection: What is the Effect of Needle Gauge and the Use of Ethyl Chloride?","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-05","conditions":"Osteoarthritis (OA) of the Knee, Fear of Needles","enrollment":88},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT04259138","phase":"PHASE4","title":"Determination of the Optimal Treatment Target in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimentiv Inc.","startDate":"2020-02-18","conditions":"Colitis, Ulcerative","enrollment":672},{"nctId":"NCT07363733","phase":"NA","title":"Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus","status":"RECRUITING","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2026-01","conditions":"Vulvar Lichen Sclerosus","enrollment":68},{"nctId":"NCT05559359","phase":"PHASE3","title":"A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2022-10-18","conditions":"Atopic Dermatitis, Eczema","enrollment":367},{"nctId":"NCT07346287","phase":"PHASE4","title":"ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy","status":"RECRUITING","sponsor":"Stratpharma AG","startDate":"2025-08-13","conditions":"Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)","enrollment":10},{"nctId":"NCT05704738","phase":"PHASE3","title":"A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-04-20","conditions":"Atopic Dermatitis","enrollment":532},{"nctId":"NCT07295678","phase":"NA","title":"URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"CEN Biotech","startDate":"2026-01-05","conditions":"Atopic Dermatitis","enrollment":44},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT06271772","phase":"PHASE3","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Bacterial Keratitis","enrollment":60},{"nctId":"NCT05969730","phase":"NA","title":"Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2023-08-15","conditions":"Atopic Dermatitis","enrollment":40},{"nctId":"NCT07278999","phase":"NA","title":"Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of Oral Lichen Planus.","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-12-01","conditions":"Oral Lichen Planus, Erosive Lichen Planus, Mucosal Lesions","enrollment":60},{"nctId":"NCT06627335","phase":"","title":"An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2023-03-27","conditions":"Pregnancy Related, Atopic Dermatitis","enrollment":5621},{"nctId":"NCT05010421","phase":"PHASE3","title":"Laser vs Clobetasol for Lichen Sclerosus","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2021-11-02","conditions":"Lichen Sclerosus","enrollment":246},{"nctId":"NCT06224348","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids","status":"COMPLETED","sponsor":"Sanofi","startDate":"2024-01-18","conditions":"Dermatitis Atopic","enrollment":643},{"nctId":"NCT07256834","phase":"PHASE1, PHASE2","title":"Comparison of Efficacy of Betamethasone Gel With Lidocaine Gel in Prevention of Post Endotracheal Intubation Sore Throat.","status":"NOT_YET_RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2025-11-22","conditions":"Post Operative Sore Throat at 6hrs and 24hrs After Endotracheal Intubation","enrollment":60},{"nctId":"NCT05724199","phase":"PHASE3","title":"A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-02-21","conditions":"Atopic Dermatitis","enrollment":746},{"nctId":"NCT07240389","phase":"NA","title":"Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.","status":"NOT_YET_RECRUITING","sponsor":"Milosz Pietrus","startDate":"2025-12-01","conditions":"Vulvar Lichen Sclerosus","enrollment":45},{"nctId":"NCT06651788","phase":"NA","title":"Does Ethyl Chloride Spray Work?","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-04-01","conditions":"Injection Fear, Injection Pain Prevention, Injection Complication","enrollment":300},{"nctId":"NCT06280716","phase":"PHASE3","title":"A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-04-24","conditions":"Atopic Dermatitis","enrollment":301},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT04202679","phase":"PHASE3","title":"Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-01-16","conditions":"Neurodermatitis","enrollment":160},{"nctId":"NCT04183335","phase":"PHASE3","title":"Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-12-12","conditions":"Neurodermatitis","enrollment":151},{"nctId":"NCT07014007","phase":"NA","title":"Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks","status":"NOT_YET_RECRUITING","sponsor":"Pierre Fabre Dermo Cosmetique","startDate":"2025-09-29","conditions":"Atopic Dermatitis","enrollment":105},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT05023304","phase":"PHASE4","title":"In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2021-08-23","conditions":"Cataract","enrollment":30},{"nctId":"NCT07114016","phase":"PHASE4","title":"Efficacy of Topical Glucosamine Versus Corticosteroid in Oral Lichen Planus","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2023-05-01","conditions":"Oral Lichen Planus","enrollment":36},{"nctId":"NCT05668455","phase":"PHASE3","title":"Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)","status":"RECRUITING","sponsor":"Agnes","startDate":"2023-05-12","conditions":"Ocular Inflammation, Ocular Prostheses","enrollment":30},{"nctId":"NCT07100145","phase":"PHASE4","title":"Efficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-01-01","conditions":"Oral Lichen Planus","enrollment":30},{"nctId":"NCT04194814","phase":"PHASE2","title":"Skin bioMARkers for Atopic Eczema Therapy Evaluation","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2020-11-20","conditions":"Atopic Eczema/Dermatitis (Non-Specific)","enrollment":37},{"nctId":"NCT06554847","phase":"PHASE3","title":"Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","startDate":"2024-09-23","conditions":"Dermatitis, Atopic, Eczema, Atopic","enrollment":400},{"nctId":"NCT04734210","phase":"PHASE2","title":"Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease","status":"COMPLETED","sponsor":"Surface Ophthalmics, Inc.","startDate":"2021-01-07","conditions":"Dry Eye Disease","enrollment":139},{"nctId":"NCT06993337","phase":"PHASE2","title":"Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-06-15","conditions":"Recurrent Aphthous Stomatitis","enrollment":63},{"nctId":"NCT05149313","phase":"PHASE3","title":"A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2021-12-23","conditions":"Dermatitis, Atopic, Eczema","enrollment":331},{"nctId":"NCT06969495","phase":"NA","title":"Pilot Clinical Study Testing Tiger Milk Mushroom Gel (Lignosus Rhinocerus TM02®) for Treating Mouth Ulcers","status":"COMPLETED","sponsor":"Mahsa University","startDate":"2023-02-01","conditions":"Mouth Ulcer","enrollment":21},{"nctId":"NCT04734197","phase":"PHASE2","title":"A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Surface Ophthalmics, Inc.","startDate":"2021-01-11","conditions":"Dry Eye Disease","enrollment":349},{"nctId":"NCT06954272","phase":"","title":"Characterisation of Skin Microstructure Under Normal and Atrophied States","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2024-07-16","conditions":"Atopic Dermatitis","enrollment":180},{"nctId":"NCT03952559","phase":"PHASE3","title":"A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2019-05-24","conditions":"Atopic Dermatitis","enrollment":516},{"nctId":"NCT06933654","phase":"NA","title":"Iris Suture Fixation vs Iris Claw for Correction of Aphakia","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-04-01","conditions":"Aphakic Eye","enrollment":50},{"nctId":"NCT06307106","phase":"NA","title":"Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2024-01-14","conditions":"Acute Post Operative Pain","enrollment":150},{"nctId":"NCT05607901","phase":"PHASE2","title":"A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-28","conditions":"Dermatologic Disease","enrollment":100},{"nctId":"NCT06118554","phase":"NA","title":"3D Printing to Improve Nasal Irrigation Outcome","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2021-11-01","conditions":"Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps","enrollment":200},{"nctId":"NCT06705387","phase":"PHASE2","title":"Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-12-23","conditions":"Eosinophilic Esophagitis","enrollment":72},{"nctId":"NCT03160885","phase":"PHASE3","title":"Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2017-06-12","conditions":"Atopic Dermatitis","enrollment":794},{"nctId":"NCT04587453","phase":"PHASE3","title":"Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2020-10-27","conditions":"Atopic Dermatitis","enrollment":106},{"nctId":"NCT03526861","phase":"PHASE3","title":"Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-06-19","conditions":"Atopic Dermatitis","enrollment":301},{"nctId":"NCT03131648","phase":"PHASE3","title":"Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2017-05-30","conditions":"Atopic Dermatitis","enrollment":802},{"nctId":"NCT03363854","phase":"PHASE3","title":"Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-02-22","conditions":"Atopic Dermatitis","enrollment":380},{"nctId":"NCT03761537","phase":"PHASE3","title":"Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-12-13","conditions":"Atopic Dermatitis","enrollment":277},{"nctId":"NCT06681090","phase":"PHASE1","title":"Different Treatment Modalities for Oral Lichen Plan","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2023-03-03","conditions":"Oral Lichen Planus","enrollment":20},{"nctId":"NCT04097730","phase":"PHASE3","title":"Steroids and Cross-linking for Ulcer Treatment","status":"COMPLETED","sponsor":"Thomas M. Lietman","startDate":"2020-09-24","conditions":"Keratitis Bacterial","enrollment":280},{"nctId":"NCT05034328","phase":"","title":"Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)","status":"COMPLETED","sponsor":"Lallemand Pharma AG","startDate":"2022-02-14","conditions":"Common Cold, Allergy","enrollment":186},{"nctId":"NCT04324359","phase":"PHASE2","title":"Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects","status":"COMPLETED","sponsor":"Surface Ophthalmics, Inc.","startDate":"2020-03-03","conditions":"Post-surgical Ocular Inflammation, Post-surgical Ocular Pain","enrollment":91},{"nctId":"NCT03861455","phase":"PHASE2","title":"Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2019-07-15","conditions":"Chronic Hand Eczema","enrollment":94},{"nctId":"NCT06533033","phase":"NA","title":"Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hams Hamed Abdelrahman","startDate":"2024-01-01","conditions":"Oral Lichen Planus","enrollment":50},{"nctId":"NCT06060301","phase":"PHASE3","title":"Topical Sulfasalazine and Oral Lichen Planus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2023-03-01","conditions":"Oral Lichen Planus, Topical Sulfasalazine, Corticosteroids","enrollment":46},{"nctId":"NCT04396990","phase":"PHASE4","title":"The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2020-06-08","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT05203315","phase":"PHASE3","title":"Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults","status":"COMPLETED","sponsor":"Austin Institute for Clinical Research","startDate":"2022-01-13","conditions":"Plaque Psoriasis","enrollment":21},{"nctId":"NCT02120079","phase":"PHASE4","title":"The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2014-02","conditions":"Dry Eye Disease","enrollment":37},{"nctId":"NCT05018806","phase":"PHASE2","title":"Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2021-09-09","conditions":"Atopic Dermatitis","enrollment":124},{"nctId":"NCT03428100","phase":"PHASE3","title":"A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-05-15","conditions":"Atopic Dermatitis","enrollment":463},{"nctId":"NCT01903317","phase":"","title":"Evaluation of Vitamin D Levels in Psoriasis Patients","status":"WITHDRAWN","sponsor":"University of California, Irvine","startDate":"2013-06","conditions":"Psoriasis","enrollment":""},{"nctId":"NCT05073172","phase":"NA","title":"StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2024-01-01","conditions":"Breast Carcinoma, Head and Neck Carcinoma, Radiation-Induced Dermatitis","enrollment":""},{"nctId":"NCT05330572","phase":"","title":"Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus","status":"RECRUITING","sponsor":"University of Aberdeen","startDate":"2022-02-07","conditions":"Lichen Planus, Oral, Lichen Planus of Vulva","enrollment":110},{"nctId":"NCT06332365","phase":"NA","title":"Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers","status":"COMPLETED","sponsor":"Pia Lopez Jornet","startDate":"2022-01-03","conditions":"Oral Lichen Planus, Oral Lichen Planus Related Stress","enrollment":60},{"nctId":"NCT01947491","phase":"PHASE3","title":"A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis","status":"COMPLETED","sponsor":"Primus Pharmaceuticals","startDate":"2013-11","conditions":"Psoriasis","enrollment":394},{"nctId":"NCT02837965","phase":"","title":"Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2013-09-26","conditions":"Bullous Pemphigoid","enrollment":149},{"nctId":"NCT05387707","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"Cara Therapeutics, Inc.","startDate":"2022-08-16","conditions":"Pruritus, Atopic Dermatitis","enrollment":287},{"nctId":"NCT06148090","phase":"NA","title":"Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP)","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2024-01-04","conditions":"Pemphigoid, Bullous, Adrenal Insufficiency","enrollment":50},{"nctId":"NCT06267066","phase":"NA","title":"Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2024-03-01","conditions":"Lichen Simplex Chronicus","enrollment":60},{"nctId":"NCT03484507","phase":"PHASE2","title":"Parasitic Ulcer Treatment Trial Pilot","status":"UNKNOWN","sponsor":"University of California, San Francisco","startDate":"2018-01-01","conditions":"Acanthamoeba Keratitis","enrollment":49},{"nctId":"NCT04200651","phase":"PHASE4","title":"Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery","status":"TERMINATED","sponsor":"The New York Eye Surgery Center","startDate":"2020-01-13","conditions":"Glaucoma, Cataract","enrollment":25},{"nctId":"NCT04220554","phase":"NA","title":"Improvement of Psoriasis Patients' Adherence to Topical Drugs","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2020-06-19","conditions":"Psoriasis Vulgaris","enrollment":103},{"nctId":"NCT02883530","phase":"","title":"Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2016-09-26","conditions":"Persistent Asthma","enrollment":160},{"nctId":"NCT05505214","phase":"PHASE2","title":"Topical Steroids & Bacterial Decolonization for Radiation Dermatitis","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-09-01","conditions":"Radiation Dermatitis","enrollment":""},{"nctId":"NCT04184999","phase":"PHASE4","title":"Effect of Intraoperative Dexamethasone on Post-op Dry Eye","status":"COMPLETED","sponsor":"SR Cornea Consultants","startDate":"2019-08-10","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT04085744","phase":"NA","title":"A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff","status":"COMPLETED","sponsor":"Derince Training and Research Hospital","startDate":"2019-11-01","conditions":"Anesthesia Intubation Complication, Intubation Complication, Sore Throat","enrollment":91},{"nctId":"NCT04765267","phase":"NA","title":"Micronutrients in Management of Symptomatic Oral Lichen Planus","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-04-01","conditions":"Oral Lichen Planus","enrollment":42},{"nctId":"NCT06119672","phase":"PHASE3","title":"Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-05-01","conditions":"Oral Lichen Planus","enrollment":36},{"nctId":"NCT04649697","phase":"PHASE3","title":"Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Rheumatoid Arthritis","enrollment":39}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6086,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Topical corticosteroids","genericName":"Topical corticosteroids","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Topical corticosteroids suppress local immune and inflammatory responses by binding to glucocorticoid receptors in skin cells. Used for Inflammatory skin conditions including eczema, psoriasis, and dermatitis, Pruritus and other allergic skin reactions, Lichen planus and other inflammatory dermatoses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}